Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis

Journal of Nuclear Medicine

Volumn 51, Issue 7, 2010, Pages 1015-1020

  Rabkin, Zoya ^a   Israel, Ora ^a,b   Keidar, Zohar ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Rambam Health Care Campus ^*  (Israel)

Author keywords

Cancer; Diabetes mellitus; Hyperglycemia; Infection; Infectious disease; Oncology; PET CT

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GLUCOSE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL EXAMINATION; COLON CANCER; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC FOOT; FALSE NEGATIVE RESULT; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT INFECTION; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFECTION; INFLAMMATION; KIDNEY CARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MESOTHELIOMA; NEOPLASM; NONHODGKIN LYMPHOMA; ONCOLOGY; PANCREAS ADENOCARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SQUAMOUS CELL CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; IMAGE PROCESSING; LABORATORY DIAGNOSIS; METABOLISM; MIDDLE AGED; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPERGLYCEMIA; IMAGE PROCESSING, COMPUTER-ASSISTED; INFECTION; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; YOUNG ADULT;

EID: 77954995400     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.074294     Document Type: Article

References (20)

1. 18F-FDG PET in diabetic cancer patients. J Nucl Med. 2009;50:178-183.
2. Bombardieri E, Aktolun C, Baum RP, et al. FDG-PET: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. 2003;30:BP115-BP124. (Pubitemid 38017443)
3. 18F-FDG PET/CT 1.0. J Nucl Med. 2006;47:885-895.
4. Diederichs CG, Staib L, Glatting G, Beger HG, Reske SN. FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. J Nucl Med. 1998;39:1030-1033.
5. Chang YC, Yen TC, Ng KK, et al. Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer? Eur J Nucl Med Mol Imaging. 2005;32:647-652.
6. 18F]FDG standardised uptake values in lung cancer? Eur J Nucl Med Mol Imaging. 2002;29:1324-1327.
7. Torizuka T, Zasadny KR, Wahl RL. Diabetes decreases FDG accumulation in primary lung cancer. Clin Positron Imaging. 1999;2:281-287.
8. 18F]fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging. 2008;52:17-29.
9. 18F-FDG PET/CT. J Nucl Med. 2007;48:1230-1236.
10. 18F-FDG PET/CT. J Nucl Med. 2008;49:1980-1985.
11. 18F- fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev. 2008;21:209-224.
12. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur J Clin Microbiol Infect Dis. 2002;21:247-257.
13. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906-1912.
14. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25:1357-1368.
15. Langen KJ, Braun U, Rota Kops E, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med. 1993;34:355-359.
16. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. J Nucl Med. 1993;34:1-6.
17. Torizuka T, Clavo AC, Wahl RL. Effect of hyperglycemia on invitro tumor uptake of tritiated FDG, thymidine, L-methionine and L-leucine. J Nucl Med. 1997;38:382-386.
18. 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med. 2005;46:2014-2019.
19. Zhuang HM, Cortes-Blanco A, Pourdehnad M, et al. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun. 2001;22:1123-1128.
20. Zhao S, Kuge Y, Tsukamoto E, et al. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions. Eur J Nucl Med. 2001;28:730-735.